Establishment of Canine Transitional Cell Carcinoma Cell Lines Harboring BRAF V595E Mutation as a Therapeutic Target

Transitional cell carcinoma (TCC) is the most common malignant tumor of the canine urinary tract and tends to have a poor prognosis due to its invasive potential. Recent studies have reported that up to 80% of canine urothelial carcinoma has the BRAF V595E mutation, which is homologous to the human...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Hyojik, Bae, Kieun, Lee, Ja Young, Kim, Jung-Hyun, Han, Hyun-Jung, Yoon, Hun-Young, Yoon, Kyong-Ah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430554/
https://www.ncbi.nlm.nih.gov/pubmed/34502061
http://dx.doi.org/10.3390/ijms22179151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430554/
https://www.ncbi.nlm.nih.gov/pubmed/34502061
http://dx.doi.org/10.3390/ijms22179151

Ejemplares similares